Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

被引：0
|
作者：
Alfred Gugerell
Ghazaleh Gouya-Lechner
Helmut Hofbauer
Maria Laggner
Franz Trautinger
Gabriele Almer
Anja Peterbauer-Scherb
Marcus Seibold
Wolfram Hoetzenecker
Christiane Dreschl
Michael Mildner
Hendrik Jan Ankersmit
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery
[2] Aposcience AG,Clinical Department for Skin and Venereal Diseases
[3] Universitaetsklinikum St.Poelten,Department of Dermatology and Venerology
[4] Austrian Red Cross Blood Transfusion Service of Upper Austria,Department of Surgery
[5] Kepler University Hospital,Research Division of Biology and Pathobiology of the Skin, Department of Dermatology
[6] Krankenhaus der Elisabethinen Klagenfurt,undefined
[7] Medical University of Vienna,undefined
来源：
Trials | / 22卷
关键词：
Diabetic foot ulcer; Secretome-based therapy; Peripheral blood mononuclear cells; Skin; Inflammation; (Impaired) wound healing; Biological; Hydrogel; Clinical trial protocol; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy and safety of myrrh in patients with incomplete abortion: a randomized, double-blind, placebo-controlled clinical study
    Vafaei, Homeira
    Ajdari, Sara
    Hessami, Kamran
    Hosseinkhani, Ayda
    Foroughinia, Leila
    Asadi, Nasrin
    Faraji, Azam
    Abolhasanzadeh, Sepideh
    Bazrafshan, Khadije
    Roozmeh, Shohreh
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01)
  • [42] Efficacy and safety of myrrh in patients with incomplete abortion: a randomized, double-blind, placebo-controlled clinical study
    Homeira Vafaei
    Sara Ajdari
    Kamran Hessami
    Ayda Hosseinkhani
    Leila Foroughinia
    Nasrin Asadi
    Azam Faraji
    Sepideh Abolhasanzadeh
    Khadije Bazrafshan
    Shohreh Roozmeh
    BMC Complementary Medicine and Therapies, 20
  • [43] Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
    van der Heijde, Desiree
    Song, In-Ho
    Pangan, Aileen
    Deodhar, Atul
    Van den Bosch, Filip
    Maksymowych, Walter P.
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Everding, Andrea
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina D.
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [44] A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure
    Xian, Shaoxiang
    Yang, Zhongqi
    Lee, Jun
    Jiang, Zhiping
    Ye, Xiaohan
    Luo, Luyi
    Jin, Lili
    Yang, Tianlun
    Ye, Suilin
    Lu, Dongfeng
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 186 : 136 - 142
  • [45] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
  • [46] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [47] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Karbalaee, Monire
    Jameie, Melika
    Amanollahi, Mobina
    TaghaviZanjani, Fateme
    Parsaei, Mohammadamin
    Basti, Fatemeh A.
    Mokhtari, Saba
    Moradi, Kamyar
    Akhondzadeh, Shahin
    SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
  • [48] A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology
    Linden, Kenneth G.
    Leachman, Sancy A.
    Zager, Jonathan S.
    Jakowatz, James G.
    Viner, Jaye L.
    McLaren, Christine E.
    Barr, Ronald J.
    Carpenter, Philip M.
    Chen, Wen-Pin
    Elmets, Craig A.
    Tangrea, Joseph A.
    Lim, Sung-Jig
    Cochran, Alistair J.
    Meyskens, Frank L., Jr.
    CANCER PREVENTION RESEARCH, 2014, 7 (05) : 496 - 504
  • [49] Treatment of functional dyspepsia with enteroplant: a double-blind randomized placebo-controlled pilot phase II clinical trial
    Sun, X.
    Ke, M.
    Wang, Z.
    Lin, L.
    Zhong, H.
    Zhang, S.
    Tao, L.
    Lin, Z.
    Wei, Z.
    Jin, X.
    Xie, X.
    Fang, Z.
    Li, X.
    Zeng, S.
    Tang, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 : 76 - 76
  • [50] Efficacy and Safety of Oral Mirodenafil in the Treatment of Erectile Dysfunction in Diabetic Men in Korea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Park, Hyun Jun
    Choi, Hyung Ki
    Ahn, Tai Young
    Park, Jong Kwan
    Chung, Woo Sik
    Lee, Sung Won
    Kim, Sae Woong
    Hyun, Jae Seog
    Park, Nam Cheol
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (08): : 2842 - 2850
12345